This inventor holds 1 USPTO granted patent. Top assignee: Cellectar, Inc.. Active years: 2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009
Title: Joseph O Nwankwo: Innovator in Cancer Imaging
Introduction
Joseph O Nwankwo is a notable inventor based in Madison, WI (US). He has made significant contributions to the field of cancer research through his innovative work in imaging and selective retention of phospholipid ether analogs. His research focuses on improving diagnostic methods for neoplastic tissues, particularly in colorectal cancer.
Latest Patents
Joseph O Nwankwo holds 1 patent for his invention titled "Imaging and selective retention of phospholipid ether analogs." This patent addresses the imaging techniques and methods for the selective retention of analogs, such as NM404, in various cancers, including colorectal cancer. His work aims to enhance the effectiveness of cancer diagnostics and treatment.
Career Highlights
Nwankwo is currently employed at Cellectar, Inc., where he continues to advance his research in cancer imaging. His role at the company allows him to collaborate with other experts in the field and contribute to innovative solutions for cancer treatment.
Collaborations
Some of his notable coworkers include Jamey Paul Weichert and Marc Longino. Their collaboration fosters a dynamic environment for research and development in cancer therapies.
Conclusion
Joseph O Nwankwo's contributions to cancer imaging and treatment represent a significant advancement in medical technology. His innovative work continues to impact the field positively, paving the way for improved diagnostic methods in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile